Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birinapant + Chemotherapy in Advanced Solid Tumors
NCT01188499Phase 2Completed
- Sponsor
- TetraLogic Pharmaceuticals
- Start
- Oct 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of birinapant in solid tumor, colorectal cancer (CRC), sponsored by TetraLogic Pharmaceuticals. Started Oct 2010; status: completed.
02
Drugs
birinapant
03
Conditions
solid tumorcolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01188499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188499.